{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T19:41:41Z","timestamp":1725478901896},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,4,30]],"date-time":"2007-04-30T00:00:00Z","timestamp":1177891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1752-1947-1-13","type":"journal-article","created":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T06:13:26Z","timestamp":1178000006000},"source":"Crossref","is-referenced-by-count":12,"title":["Severe heparin-induced thrombocytopenia: when the obvious is not obvious, a case report"],"prefix":"10.1186","volume":"1","author":[{"given":"Graham M","family":"Cormack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,30]]},"reference":[{"issue":"suppl F","key":"13_CR1","first-page":"14F","volume":"12","author":"KR Campbell","year":"2000","unstructured":"Campbell KR, Mahaffey KW, Lewis BE: Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invas Cardiol. 2000, 12 (suppl F): 14F-19F.","journal-title":"J Invas Cardiol"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.104.518563","volume":"111","author":"IK Jang","year":"2005","unstructured":"Jang IK, Hursting MJ: When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005, 111: 2671-2683. 10.1161\/CIRCULATIONAHA.104.518563.","journal-title":"Circulation"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","volume":"126","author":"TE Warkentin","year":"2004","unstructured":"Warkentin TE, Greinacher A: Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126: 311S-337S. 10.1378\/chest.126.3_suppl.311S.","journal-title":"Chest"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1001\/archinte.164.18.1961","volume":"164","author":"L Rice","year":"2004","unstructured":"Rice L: Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient). Arch Intern Med. 2004, 164: 1961-1964. 10.1001\/archinte.164.18.1961.","journal-title":"Arch Intern Med"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1365-2141.2000.01966.x","volume":"109","author":"J Harenberg","year":"2000","unstructured":"Harenberg J, Huhle G, Giese C: Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol. 2000, 109: 182-186. 10.1046\/j.1365-2141.2000.01966.x.","journal-title":"Br J Haematol"},{"key":"13_CR6","doi-asserted-by":"crossref","unstructured":"Warkentin TE: Heparin-induced thrombocytopenia: diagnosis and management. Circulation. 110 (18): e454-8. 10.1161\/01.CIR.0000147537.72829.1B. 2004 Nov 2;","DOI":"10.1161\/01.CIR.0000147537.72829.1B"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","volume":"101","author":"TE Warkentin","year":"1996","unstructured":"Warkentin TE, Kelton JG: A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996, 101: 502-507. 10.1016\/S0002-9343(96)00258-6.","journal-title":"Am J Med"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1160\/TH05-03-0154","volume":"94","author":"A Greinacher","year":"2005","unstructured":"Greinacher A, Farner B, Kroll H: Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis: a retrospective analysis of 408 patients. Thromb Haemost. 2005, 94: 132-135.","journal-title":"Thromb Haemost"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/archinte.164.4.361","volume":"164","author":"J Hirsh","year":"2004","unstructured":"Hirsh J, Heddle N, Kelton JG: Treatment of heparin-induced thrombocytopenia: a critical review. Arch Int Med. 2004, 164: 361-369. 10.1001\/archinte.164.4.361.","journal-title":"Arch Int Med"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","volume":"106","author":"DE Wallis","year":"1999","unstructured":"Wallis DE, Workman DL, Lewis BE: Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med. 1999, 106: 629-635. 10.1016\/S0002-9343(99)00124-2.","journal-title":"Am J Med"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","volume":"126","author":"TE Warkentin","year":"2004","unstructured":"Warkentin TE, Greinacher A: Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126: 311S-337S. 10.1378\/chest.126.3_suppl.311S.","journal-title":"Chest"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/01.CIR.99.1.73","volume":"99","author":"A Greinacher","year":"1999","unstructured":"Greinacher A, Volpel H, Janssens U: Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation. 1999, 99: 73-80.","journal-title":"Circulation"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1345\/aph.1C187","volume":"37","author":"MG Reichert","year":"2003","unstructured":"Reichert MG, MacGregor DA, Kincaid EH: Excessive argatroban anticoagulation for heparin-induced thrombocytopenia. Ann Pharmacother. 2003, 37: 652-654. 10.1345\/aph.1C187.","journal-title":"Ann Pharmacother"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.104.518563","volume":"111","author":"IK Jang","year":"2005","unstructured":"Jang IK, Hursting MJ: When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005, 111: 2671-2683. 10.1161\/CIRCULATIONAHA.104.518563.","journal-title":"Circulation"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-1-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-1-13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-1-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T16:17:07Z","timestamp":1556381827000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-1-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,30]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-1-13","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,30]]},"article-number":"13"}}